We summarize advances in research on urate -lowering drugs including urate transporter inhibitors, xanthine oxidase inhibitors as well as novel urate -lowering drugs, and evaluate the effect of urate-lowering therapy on the rate of hyperuricaemia-related diseases
In fulfilling this protective role, reduced glutathione is converted into oxidized glutathione, at which point it becomes inactive
Pratley RE, Aroda VR, Lingvay I (2018) Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
[1] [8] It can be used as monotherapy when metformin is inappropriate, or as an add-on therapy in combination with other diabetes medications
The sodium excretion, glycemic correction, and gastric slowdown causing the headaches are the same mechanisms driving weight loss and metabolic improvement
Independent risk factors for atrial fibrillation in a population-based cohort